Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT03664401

A Clinical Trial to Evaluate Kerecis Oral™ Compared to Autogenous Free Gingival Graft (AFGG) Tissue to Augment Gingival Soft Tissue and Wound Healing

Sponsor: Kerecis Ltd.

Conditions Mucogingival Deformity - Insufficient Keratinized Tissue

Interventions Free Gingival Graft Kerecis Oral™

Updated 4 times since 2018 Last updated: Sep 11, 2018 Started: Sep 1, 2016 Primary completion: Sep 1, 2017 Completion: Dec 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Mucogingival Deformity - Insufficient Keratinized Tissue and is currently completed. Kerecis Ltd. leads this study, which shows 4 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Oct 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1

First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kerecis Ltd.
Tufts University School of Dental Medicine

Data source: Kerecis Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.